Literature DB >> 8423999

Inducible formation of liver tumors in transgenic mice.

U Rüther1, C Woodroofe, E Fattori, G Ciliberto.   

Abstract

Transgenic mice have been generated with an inducible SV40 t/T antigen construct with the aim of analysing the early changes that take place in the course of liver tumorigenesis. The strictly liver-specific human C-reactive protein (CRP) gene promoter was chosen for the control of the transgene expression because this promoter can be turned on transiently by injection of bacterial lipopolysaccharide. Among 10 independently derived CRP-Tag mouse lines five showed inducible expression of the CRP-Tag transgene in liver. However, only one had a tight control of the transgene with virtually no expression under physiological conditions and high levels of Tag expression after stimulation. Females of this line were used to analyse the progression of liver alterations upon repeated induction of the t/T antigen for different lengths of time. The first signs of transgene-induced liver alterations could be monitored by the activation of the marker enzyme gamma-glutamyltranspeptidase 30 days after the start of the induction program. After 90 days hepatocellular carcinomas were already detectable. Thus, CRP-Tag mice constitute an excellent system to analyse the sequential events that take place during liver carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8423999

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  5 in total

1.  Interleukin-6 is necessary, but not sufficient, for induction of the humanC-reactive protein gene in vivo.

Authors:  B Weinhold; A Bader; V Poli; U Rüther
Journal:  Biochem J       Date:  1997-08-01       Impact factor: 3.857

2.  Transgenic hepatocarcinogenesis in the rat.

Authors:  J R Hully; Y Su; J K Lohse; A E Griep; C A Sattler; M J Haas; Y Dragan; J Peterson; M Neveu; H C Pitot
Journal:  Am J Pathol       Date:  1994-08       Impact factor: 4.307

3.  The H19 locus acts in vivo as a tumor suppressor.

Authors:  Tomomi Yoshimizu; Audrey Miroglio; Marie-Anne Ripoche; Anne Gabory; Maria Vernucci; Andrea Riccio; Sabine Colnot; Cécile Godard; Benoit Terris; Hélène Jammes; Luisa Dandolo
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-21       Impact factor: 11.205

4.  Mechanisms of single-stranded phosphorothioate modified antisense oligonucleotide accumulation in hepatocytes.

Authors:  Erich Koller; Thomas M Vincent; Alfred Chappell; Soma De; Muthiah Manoharan; C Frank Bennett
Journal:  Nucleic Acids Res       Date:  2011-02-23       Impact factor: 16.971

5.  Insulin-like growth factor II signaling in neoplastic proliferation is blocked by transgenic expression of the metalloproteinase inhibitor TIMP-1.

Authors:  D C Martin; J L Fowlkes; B Babic; R Khokha
Journal:  J Cell Biol       Date:  1999-08-23       Impact factor: 10.539

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.